The cluster is small in dollar terms ($6.4M net vs. $3.6B market cap) and lacks insider corroboration. The 45-day reporting lag means these positions may already be unwound. Monitor next 13F filing for persistence of the buying pattern.
ACAD drugs
ACAD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 3 $20.57entry
- T+1 · 13d ago +4.38%α +2.72% · $21.47
- T+5 · 7d ago −11.13%α −10.55% · $18.28
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Five asset managers increased their ACAD positions in Q3 2026, with two funds more than doubling their stakes. The aggregate buying totaled $6.4M in net additions, concentrated in Assenagon's $6.2M increase. No institutional sellers were reported. Insider activity was absent, and the 13F data is 45+ days stale, limiting the signal's timeliness.
Key Financial Metrics
Institutional Positions
Net institutional flow: $6.4M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | DOUBLED | +1489.2% | $6.7M | $6.2M |
| Farther Finance Advisors | DOUBLED | +996.4% | $182.0K | $161.0K |
| Alps Advisors | ADD | +26.6% | $5.0M | $40.0K |
Key Facts
- 5 institutional buyers added a net $6.4M in ACAD positions during Q3 2026
- Assenagon Asset Management nearly doubled its stake, adding $6.2M (1,489% increase in shares)
- Farther Finance Advisors more than doubled its position, adding $161K (996% increase in shares)
- 0 institutional sellers reported
- Insider activity was minimal (1 sell of $69K in the 30 days prior) and the 13F-insider confluence score is low at 18/100, labeled 'divergent'
- No open-market insider buying corroborated the institutional cluster
Financial Impact
5 institutions accumulated $6.4M in net new positions; no selling activity. The largest move was Assenagon's $6.2M addition.
Risk Factors
- 13F data is 45+ days stale; positions may have been reversed since quarter-end
- No insider buying to confirm the institutional thesis
- Cluster size is modest relative to market cap and normal daily volume
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ACAD-2026-Q3 |
Track record
14 reports on ACAD
1 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +5.01% at T+20 after the May 6, 2026 report. 2 of 5 went positive at some point.
Filters
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $18.28 settles Dec 9
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $21.24 settles Dec 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Viewing Entry $20.57 settles Dec 2
- Oct 23, 202624d ago 8-K Neutral 3/10 Entry $19.74 settles Nov 23
- Sep 24, 20267w ago 8-K Bullish 6/10 Entry $20.68 to $19.73 ▼ −4.59% −3.12% vs SPY
- Sep 11, 20269w ago 8-K Neutral 3/10 Entry $27.52 to $19.41 ▼ −29.47% −31.73% vs SPY
- Aug 16, 202613w ago Institutional Cluster Mixed 5/10 Entry $29.01 to $26.76 ▼ −7.76% −5.78% vs SPY
- Aug 7, 202614w ago Insider Cluster Neutral 2/10 Entry $29.39 to $27.58 ▼ −6.16% −5.24% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 6/10 Entry $21.39 to $26.41 ▼ −23.47% −21.58% vs SPY
- May 6, 202627w ago 8-K Bearish 6/10 Entry $22.56 to $21.43 ▲ +5.01% +8.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers